A peer study from France recorded a similar percentage (50%) of p16 expression in cutaneous BCCs [18]; however, a study from Iran recorded a much higher percentage (79%) of positive staining BCC cases [2]. This evidence concerns the gene CDKN2A and skin basal cell carcinoma.